372 related articles for article (PubMed ID: 16866578)
21. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
Abu-Raddad LJ; Sabatelli L; Achterberg JT; Sugimoto JD; Longini IM; Dye C; Halloran ME
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13980-5. PubMed ID: 19666590
[TBL] [Abstract][Full Text] [Related]
22. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally.
Dye C; Watt CJ; Bleed DM; Hosseini SM; Raviglione MC
JAMA; 2005 Jun; 293(22):2767-75. PubMed ID: 15941807
[TBL] [Abstract][Full Text] [Related]
23. Update in tuberculosis and nontuberculous mycobacterial disease 2011.
Nahid P; Menzies D
Am J Respir Crit Care Med; 2012 Jun; 185(12):1266-70. PubMed ID: 22707733
[TBL] [Abstract][Full Text] [Related]
24. Beyond DOtS: avenues ahead in the management of tuberculosis.
Chaudhury RR; Thatte U
Natl Med J India; 2003; 16(6):321-7. PubMed ID: 14765625
[TBL] [Abstract][Full Text] [Related]
25. Impact of HIV on novel therapies for tuberculosis control.
Sánchez MS; Lloyd-Smith JO; Porco TC; Williams BG; Borgdorff MW; Mansoer J; Salomon JA; Getz WM
AIDS; 2008 May; 22(8):963-72. PubMed ID: 18453856
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of tuberculosis in the Americas: the Stop TB strategy and the millennium development goals.
Ramon-Pardo P; Del Granado M; Gerger A; Canela Soler J; Mir M; Armengol R; Lopez Olarte RA; Rodriguez R
Int J Tuberc Lung Dis; 2009 Aug; 13(8):969-75. PubMed ID: 19723376
[TBL] [Abstract][Full Text] [Related]
27. Progress toward tuberculosis control--India, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(11):229-32. PubMed ID: 11925019
[TBL] [Abstract][Full Text] [Related]
28. [Current treatment of tuberculosis].
García Ramos R; Lado Lado FL; Túnez Bastida V; Pérez del Molino Bernal ML; Cabarcos Ortiz de Barrón A
An Med Interna; 2003 Feb; 20(2):91-100. PubMed ID: 12703164
[TBL] [Abstract][Full Text] [Related]
29. [Global situation of TB and its control].
Shimao T
Kekkaku; 1999 Feb; 74(2):83-90. PubMed ID: 10191600
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic review: tuberculosis.
Houston S; Pozniak A; Ray CS
Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
[TBL] [Abstract][Full Text] [Related]
31. Scale up: meeting targets in global tuberculosis control.
Elzinga G; Raviglione MC; Maher D
Lancet; 2004 Mar; 363(9411):814-9. PubMed ID: 15016493
[TBL] [Abstract][Full Text] [Related]
32. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
Ushio M
Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
[TBL] [Abstract][Full Text] [Related]
33. Are TB control programmes in South Asia ignoring children with disease? A situational analysis.
Shakoor S; Qamar FN; Mir F; Zaidi A; Hasan R
Arch Dis Child; 2015 Feb; 100(2):198-205. PubMed ID: 25480926
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
Leimane V; Leimans J
Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
[TBL] [Abstract][Full Text] [Related]
35. [Anti-tuberculosis chemotherapy].
Wada M
Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
[TBL] [Abstract][Full Text] [Related]
36. Tuberculosis problems in the Asia-Pacific region.
Shimouchi A
Respirology; 2001 Mar; 6(1):75-8. PubMed ID: 11264768
[TBL] [Abstract][Full Text] [Related]
37. [How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].
Ishikawa N
Kekkaku; 2005 Feb; 80(2):89-94. PubMed ID: 15920981
[TBL] [Abstract][Full Text] [Related]
38. Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.
Fofana MO; Knight GM; Gomez GB; White RG; Dowdy DW
PLoS One; 2014; 9(5):e96389. PubMed ID: 24816692
[TBL] [Abstract][Full Text] [Related]
39. Low access to a highly effective therapy: a challenge for international tuberculosis control.
Dye C; Watt CJ; Bleed D
Bull World Health Organ; 2002; 80(6):437-44. PubMed ID: 12131999
[TBL] [Abstract][Full Text] [Related]
40. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
